Dengue hemorrhagic fever
1995; Wiley; Volume: 5; Issue: 4 Linguagem: Inglês
10.1002/rmv.1980050403
ISSN1099-1654
Autores Tópico(s)Viral Infections and Outbreaks Research
ResumoReviews in Medical VirologyVolume 5, Issue 4 p. 193-203 Classic Paper Dengue hemorrhagic fever M. Sinniah, M. Sinniah Department of Virology, (Clinical Tropical Medicine Branch), Institute for Medical Research, Jalan Pahang 50588 Kuala Lumpur, West MalaysiaSearch for more papers by this authorA. Igarashi, A. Igarashi Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki City, Japan 852Search for more papers by this author M. Sinniah, M. Sinniah Department of Virology, (Clinical Tropical Medicine Branch), Institute for Medical Research, Jalan Pahang 50588 Kuala Lumpur, West MalaysiaSearch for more papers by this authorA. Igarashi, A. Igarashi Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki City, Japan 852Search for more papers by this author First published: December 1995 https://doi.org/10.1002/rmv.1980050403Citations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 C. T. Onion (ed.) (1973). The Shorter Oxford English Dictionary on Historical Principles, Oxford University Press, Oxford. 2 Rush, B. (1989). An account of the bilious remitting fever as it appeared in Philadelphia in the summer and autumn of the year 1870. In, Medical Inquiries and Observations, 2nd edn, p. 104. Prichard &Hall, Philadelphia. 3 Hammon, V. M., Rudnick, A. and Sather, G. E. (1960). Viruses associated and epidemic hemorrhagic fevers of the Philippines and Thailand. Science 131, 1102–1103. 4 James, W. and Le Duc, Global situation on Dengue fever. World Health Organisation Regional Office for Western Pacific Report. (WP) CDS (O)/ICP/OCD/003-E, Report Series Number. RS/94/GE/22 (JPN): 24. 5 Russel, P. K. and Nisalak, A. (1967). Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 99, 291–296. 6 Westaway, E. G., Brinton, M. A., Gaidomich, S. Y. et al. (1985). Flaviviridae. Interuirology 24, 183–192. 7 Wengler, G. (1991). Family Flaviviridae. In, Classification and Nomenclature of Viruse, ed. by R. I. B. Francki, C. M. Fauquet, D. L. Knudson and F. Brown, Arch Virol. Suppl 2, 233–23. 8 Clarke, D. H. and Casals, (1995). Arboviruses; group B. In, Viral and Rickettsial Infections of Man, ed. by F. L. Horsfall Jr and I. Tamm, pp. 606–658. 9 T. O. Berge (ed) (1975). International Catalogue of Arboviruses. DHEW Publication No. (CDC) 75–8301, Government Printing Office, Washington, DC. 10 Zhang, Y. M., Hayes, E. P., McCarty, T. C. et al. (1988). Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J. Virol. 62, 3027–3031. 11 Rosen, L., Shroyer, D. A., Tesh, R. B. et al. (1983). Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti. Am J. Trop. Med. Hyg. 32, 1108–1119. 12 Khin, M. M. and Than, K. A. (1983). Transovarial transmission of dengue 2 virus by Aedes aegypti in nature. Am. J. Trop. Med. Hyg. 32, 590–594. 13 Kouri, G. P., Guzman, M. G., Bravo, J. R. and Triana, C. (1989). Dengue hemorrhagic fever/dengue shock syndrome. Lessons from the Cuban epidemic. Bull. WHO 67, 375–380. 14 Ungchusak, K. and Kunasol, P. (1988). Dengue hemorrhagic fever in Thailand. Southeast Asian J. Trop. Publ. Hlth. 19, 487–490. 15 Kouri, G., Guzman, M. G. and Bravo, J. R. (1986). Hemorrhagic dengue in Cuba: history of an epidemic. Bull. PAHO 20, 24–30. 16 Halstead, S. B. (1993). Global epidemiology of dengue: health systems in disarray. Trop. Med. 35, 137–146. 17 CDC (1990). Case definitions for public health surveillance. MMWR 39, 10–11. 18 Mills, G. D. and Jones, P. D. (1991). Clinical spectrum of dengue fever in travellers. New Zealand Med. J. 104, 228–230. 19 Jacobs, N. G., Brook, M. G., Weir, W. R. C. and Bannister, B. A. (1991). Dengue hemorrhagic fever: a risk of returning home. Br. Med. J. 302, 828–829. 20 Rudnick, A., Marchette, N. J. and Garcia, R. (1967). Possible jungle dengue-recent studies and hypothesis. Jpn J. Med. Sci. Biol. 20, 69–74. 21 Pant, C. P. and Self, L. S. (1993). Vector ecology and bionomics. Monograph on Dengue/Dengue Hemorrhagic Fever, pp. 121–138. World Health Organization, Regional Office for South-East Asia, New Delhi. 22 Lloyd, L. S. (1992). Results of a community based Aedes aegypti control intervention. In, Dengue, A Worldwide Problem, A Common Strategy, ed. by S. B. Halstead and H. Gomez-Dantes, 281–291. Ministry of Health, Mexico, &Rockefeller Foundation. 23 Watts, D. M., Burke, D. S. and Harrison, B. H. (1987). Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am. J. Trop. Med. Hyg. 36, 143–152. 24 Halstead, S. B. (1966). Mosquito borne hemorrhagic fevers of South and Southeast Asia. Bull. WHO 35, 3. 25 Chungue, E., Speilgel, A., Philippon, G. et al. (1990). Dengue and dengue hemorrhagic fever in French Polynesia: a comparative study of two successive epidemics. In, Proceedings of the International Symposium of Dengue and Dengue Haemorrhagic Fever, Bangkok, Thailand, p. 34. 26 Halstead, S. B. (1980). Immunological parameters of togavirus disease syndromes. In, The Togaviruses, ed. by R. W. Schlesinger, pp. 107–173. Academic Press, New York. 27 World Health Organization (1986). Dengue Hemorrhagic Fever; Diagnosis, Treatment and Control, WHO, Geneva. 28 Tsai, C. J., Kuo, C. H., Chem, P. C. et al. (1991).Upper gastrointestinal bleeding in dengue fever. Am. J. Gastroenterol. 86, 33–55. 29 Sucharit, S. (1993). Epidemiological situation of Dengue in Thailand. Trop. Med. 35(4), 173–177. 30 Fukunagha, T., Phommasack, B., Bounlu, K. et al. (1993). Epidemiological situation of dengue infection in Lao PDR. Trop. Med. 35(4), 219–227. 31 Nimannitya, S. (1993). Management of dengue and dengue hemorrhagic fever. In, Monograph of Dengue/Dengue Hemorrhagic Fever, pp. 55–61. World Health Organization, Regional Office for South-East Asia, New Delhi. 32 Nimmannitya, S., Thisyakorn, U. and Hemsrichart, V. (1987). Dengue hemorrhagic fever with unusual manifestations. Southeast Asian J. Trop. Med. Publ. Hlth. 18(3), 398–406. 33 Wulur, H., Djoharman, S., Rumalean, L. et al. (1982). Reye's syndrome associated with dengue virus infection. In, Fourth Asian Congress of Paediatrics, Seoul, Korea. 34 Wong, H. B. and Tan, G. (1967). Cardiac involvement in hemorrhagic fever. J. Singapore Paed. Soc. 9(6), 28–36. 35 Yusoff, K., Roslawati, J., Sinniah, M. and Khalid, B. (1993). Electrocardiographic and echocardiographic changes during the acute phase of Dengue infection in adults. J.H.K. Coll. Cardiol. 1, 93–96. 36 Suvatte, V., Vajaradul, C. and Laohapand, T. (1990). Liver failure and hepatic encephalopathy in dengue hemorrhagic fever/dengue shock syndrome: a correlation study with acetaminophen usage. Southeast Asian J. Trop. Med 24, 694–695. 37 Sirinavin, S. and Hathirat, P. (1990). Problems in severity grading of Dengue Haemorrhagic Fever. In International Symposium on Dengue and Dengue Haemorrhagic fever, Thailand. Southeast Asian J. Trop. Med. Publ. Hlth. 21(4), 696. 38 Tassniyom, S., Chirawatkul, A. and Rojanasuphot, S. (1982). Failure of high dose steroids on in averting death in severe dengue shock syndrome: A double blind randomised controlled trial. Southeast Asian J. Trop. Med. Publ. Hlth. 21(4), 698. 39 Halstead, S. B. (1970). Observations related to pathogenesis of dengue hemorrhagic fever. VI Hypothesis and discussion. Yale J. Biol. Med. 42, 350–362. 40 World Health Organisation (1973). Pathogenetic mechanisms in dengue hemorrhagic fever; report of an international collaborative study. Bull. WHO 48, 117–133. 41 Gubler, D. J., Reed, D., Rosen, L. and Hitchock, J. C. (1978). Epidemiologic, clinical and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27, 581–589. 42 Scott, R. M., Nimmannitya, S., Bancroft, W. H. and Mansuwan, P. (1976). Shock syndrome in primary dengue infections. Am. J. Trop. Med. Hyg. 25, 866–874. 43 Sangkawibha, N., Rojanasuphot, S., Ahandrik, S. et al. (1984). Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand, I. The 1980 outbreak. Am. J. Epidemiol. 120, 653–669. 44 Lam, S. K., Chew, C. B. and Poon, G. K. (1986). Isolation of dengue viruses by intracerebral inoculation of mosquito larvae. J. Virol. Methods 14, 133–140. 45 Morita, K., Tanaka, K. and Igarashi, A. (1991). Rapid identification of dengue virus serotypes by using polymerase chain reaction. J. Clin. Microbiol. 29, 2107–2110. 46 Saat, Z., Thayan, R., Balasubramaniam, V. et al. (1994). Use of the reverse transcriptase polymerase chain reaction for diagnosis of dengue virus infection compared to IgM-ELISA. Trop. Med. 36(3), 75–81. 47 Clarke, D. H. and Casals, J. (1958). Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg. 561, 573. 48 Cardosa, M. J., Tio, P. H. and Noorsham, S. (1988). Development of a dot enzyme inmmunoassay for dengue 3: a sensitive method for the detection of antidengue antibodies. J. Virol. Methods. 22, 81–88. 49 Fang, R., Sinniah, M. and Kuen, L. S. (1992). Use of dengue blot in dengue diagnosis: the Malaysian experience. Mal. J. Pathol. 14(2), 117–120. 50 Sabin, A. B. and Schlesinger, R. W. (1945). Production of immunity to dengue with virus modified by propagation in mice. Science 101, 640–642. 51 Hotta, S. (1954). Experiments in active immunization against dengue with mouse-passaged unmodified virus. Acta Tropica 11, 97–104. 52 Schlesinger, R. W., Gordon. I., Frankel, J. W. et al. (1956). Clinical and serological response of man to immunization with attenuated dengue and yellow fever viruses. J. Immunol. 77, 352–364. 53 Wisseman, C. L. Jr., Sweet, B. H., Rosenzweig, E. C. and Eyler, O. R. (1963). Attempted living type 1 dengue vaccines. Am. J. Trop. Med. Hyg. 12, 620–623. 54 Eckels, K. H., Brandt, W. E., Harrison, V. R. et al. (1976). Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect. Immun. 14, 1221–1227. 55 Scott, R. M., Eckels, K. H., Bancroft, W. H. et al. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever status. J. Infect. Dis. 148, 1055–1060. 56 Bancroft, W. H., Scott, R. M., Eckels, K. H. et al. (1984). Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J. Infect. Dis. 149, 1005–1010. 57 Eckels, K. H., Scott, R. M., Bancroft, W. H. et al. (1984). Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine. Am. J. Trop. Med. Hyg. 33, 684–689. 58 McKee, K. T. Jr., Bancroft, W. H., Eckels, K. H. et al. (1987). Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am. J. Trop: Med. Hyg. 36, 435–442. 59 Bhamarapravati, N., Yoksan, S., Chayaniyayothin, T. et al. (1987). Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PKD 53): clinical; immunological and biological responses in adult volunteers. Bull. WHO 65, 189–195. 60 Bhamarapravati, N. and Yoksan, S. (1990). The clinical trial of trivalent dengue vaccine. Southeast Asian, J. Trop. Med. Publ. Hlth. 21, 709. 61 Bhamarapravati, N., Yoksan, S., Angsubhakorn, S. et al. (1993). Clinical trials of live attenuated dengue vaccine-current status. In, Abstract III-International Symposium on Current Situation of Dengue Virus Infection and its Control. October 1993, Nagasaki. 62 Bancroft, W. H., Scott, M. N., Brandt, W. E. et al. (1982). Dengue-2 vaccine infection of Aedes aegypti mosquitoes by feeding on viremic recipients. Am. J. Trop. Med. Hyg. 31, 1229–1231. 63 Schoepp, R. J., Beaty, B. J. and Eckels, K. H. (1991). Infection Aedes albopictus and Aedes aegypti mosquitoes with dengue parent and progeny candidate vaccine viruses: a possible marker of human attenuation. Am. J. Trop. Med. Hyg. 45, 202–210. 64 Khin, M. M., Jirakanjanakit, N., Yoksan, S. and Bhamarapravati, N. (1994). Infection, dissemination, transmission, and biological attributes of dengue-2 PDK 52 candidate vaccine virus after oral infection in Aedes aegypti. Am. J. Trop. Med. Hyg. 51, 864–869. 65 Brandt, W. E. (1988). Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. J. Infect. Dis. 157, 1105–1111. 66 Bray, M., Zhao, B., Markoff, L. et al. (1989). Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. J. Virol. 63, 2853–2856. 67 Lai, C. J., Zhang, Y. M., Bray, M. et al. (1989). Use of dengue virus structural protein and nonstructural protein NS1 produced by recombinant baculovirus for immunization against dengue virus infection. In, Vaccines 89, Modern Approaches to Vaccines Including Prevention of AIDS, ed. by R. A. Lerner, M. Chanock and F. Brown, pp. 351–356. Cold Spring Harbor Laboratory Press, New York. 68 Faghny, R., Burrous, J. and Putnak, R. (1994). Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge. Am. J. Trop. Med. Hyg. 50, 322–328. 69 Bray, M. and Lai, C. J. Role of dengue virus membrane protein in resistance. In, Vaccines 91, Modern Approaches to New Vaccines Including Prevention of AIDS, ed. By R. M. Chanock, H. S. Ginsberg, F. Brown and R. A. Lerner, pp. 245–249. Cold Spring Harbor Laboratory Press, New York. 70 Eckels, K. H., Dubois, D. R., Summers, P. L. et al. (1994). Immunization of monkeys with baculovirus- dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Am. J. Trop. Med. Hyg. 50, 472–478. 71 Rice, C. M., Grakuri, A., Galler, R. and Chambers, T. J. (1989). Transcription of infectious yellow fever virus RNA from full-length cDNA templates produced by in vitro ligation. New Biologist 1, 285–296. 72 Lai, C. J., Zhao, B., Hori, H. and Bray, M. (1991). Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl Acad. Sci. 88, 5139–5143. 73 Lai, C. J., Men, R., Pethel, M. and Bray, M. (1992). Infectious RNA transcribed from stably cloned dengue virus cDNA: construction of growth resistant dengue virus mutants. In, Vaccines 92, Approaches to New Vaccines Including Prevention of AIDS, ed. by F. Brown, R. M. Chanock, H. S. Ginsberg and R. A. Lerner, pp. 265–270. Cold Spring Harbor Laboratory Press, New York. 74 Bray, M. and Lai, C. J. (1992). Construction and characterization of chimeric dengue viruses. In, Vaccines 92, Modern Approaches to New Vaccines Including Prevention of AIDS, ed. by F. Brown, R. M. Chanock, H. S. Ginsberg and R. A. Lerner, pp. 271–272. Cold Spring Harbor Laboratory Press, New York. 75 Chan, Y. C., Goh, K. T., Heng, B. H. and Tan, B. T. (1993). Epidemiology of dengue in Singapore- current situation. Trop. Med. 35, 189–194. 76 Ha, B. K., Do, Q. H., Vu, T. Q. H. et al. (1993). Epidemiology of dengue in South Vietnam and the strategy of its control. Trop. Med. 35, 179–184. 77 Hoang, T. N., Tran, V. T., Nguyen, C. T. et al. (1995). The effect of Olyset Net screen to control the vector of dengue fever in Vietnam. Dengue News, in press. 78 Gubler, D. J. (1989). Aedes aegypti and Aedes aegypti borne disease control in the 1990s: top down or bottom up. Am. J. Trop. Med. Hyg. 40, 571–578. Citing Literature Volume5, Issue4December 1995Pages 193-203 ReferencesRelatedInformation
Referência(s)